UNM
67
-7
NWSA
54
-4
AES
37
-3
STT
42
-6
K
60
9
EMC
18
-12
EMN
55
-4
VRSN
53
-2
VNO
56
-3
MSFT
43
-3
TXN
33
-3
EMR
47
-3
FIS
46
-4
ZION
46
-4
DTE
56
-3
URBN
24
-4
PNR
53
-3
CHK
5
-17
WM
64
-4
GS
50
-15
UNM
67
-7
NWSA
54
-4
AES
37
-3
STT
42
-6
K
60
9
EMC
18
-12
EMN
55
-4
VRSN
53
-2
VNO
56
-3
MSFT
43
-3
TXN
33
-3
EMR
47
-3
FIS
46
-4
ZION
46
-4
DTE
56
-3
URBN
24
-4
PNR
53
-3
CHK
5
-17
WM
64
-4
GS
50
-15
Financhill
Back

SpringWorks Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
22

SWTX
SpringWorks Therapeutics

Last Price:
38.69
Seasonality Move:
12.83%
Sell
15

ALNY
Alnylam Pharmaceuticals

Last Price:
246.59
Seasonality Move:
6.72%
Sell
22
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $38.70. The Score for SWTX is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
15
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $246.78. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $38.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $246.78
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.86 Buy
Relative Strength Index (14 RSI): 48.43 Sell
Chaikin Money Flow: -246559 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.31 - 41.03) Buy
Bollinger Bands (100): (36.62 - 43.22) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.98 Buy
Relative Strength Index (14 RSI): 39.94 Sell
Chaikin Money Flow: -378372 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (258.04 - 277.96) Sell
Bollinger Bands (100): (152.5 - 260.08) Buy

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.65 Sell
20-day SMA: 39.22 Sell
50-day SMA: 38.12 Buy
200-day SMA: 40.78 Sell
8-day EMA: 40.17 Sell
20-day EMA: 39.42 Sell
50-day EMA: 38.9 Sell
200-day EMA: 38.59 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 264.46 Sell
20-day SMA: 268.49 Sell
50-day SMA: 256.91 Sell
200-day SMA: 187.09 Buy
8-day EMA: 259.34 Sell
20-day EMA: 263.1 Sell
50-day EMA: 247.85 Sell
200-day EMA: 202.56 Buy

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, an increase next quarter of $0.57 per share, an increase this year of $1.06 per share, and an increase next year of $1.38 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):